How about Shenwei Pharmaceutical? How is the work in the workshop of Shenwei Pharmaceutical

The company has successively won hundreds of honorable titles, such as China's Top 10 Most Appreciated Pharmaceutical Enterprises, China's Outstanding Enterprise in Harmonious Labor Relations, China's Enterprise Culture Excellence Award, China's Top 100 Employers in Top 100 Industries, China's Top 100 Growing Enterprises, the National "May Day" Labor Award, and the National Advanced Collective of Traditional Chinese Medicine System.

Shenwei Pharmaceutical Co., Ltd. mainly focuses on the development of new dosage forms and new products of modern Chinese medicine, and has formed a strong advantageous product portfolio featuring three major dosage forms of modern Chinese medicine injection, Chinese medicine soft capsules and Chinese medicine granules, and the output of modern Chinese medicine injection and soft capsules ranks first in China. The market share of the fist products Qingkailing Injection, Shenmai Injection and Wufu Xinnaoqing Soft Capsule ranks first in the country. 13 varieties of Shenwei Huoxiang Zhengqi Soft Capsules and Qingkailing Soft Capsules have been listed as national protected varieties of traditional Chinese medicine, and Wufu Xinnao Qing Soft Capsules and Shenwei Huoxiang Zhengqi Soft Capsules have been recognized as green standard products by the China Chamber of Commerce for Import and Export of Medicines and Health Products.

Shenwei Pharmaceutical has modern production facilities and large-scale commercial production capacity. Through the introduction of advanced production equipment and technology at home and abroad, strengthen enterprise management, improve product quality, through the comprehensive use of new technologies, new processes and new equipment for the production of modern Chinese medicine, the use of new technologies such as fingerprint, supercritical extraction, ultrafine grinding, etc., the dynamic countercurrent extraction of traditional Chinese medicine, injection washing, filling and sealing linkage production line, soft capsule automatic packaging line and other leading process equipment, widely used computer control technology, to achieve the standardization of traditional Chinese medicine production, the modernization of traditional Chinese medicine dosage forms, the standardization of quality control, The automation of production equipment has enabled Shenwei's modern traditional Chinese medicine products to meet the modern standards of "safe, effective, stable and controllable", and has the advantages of "three small (small dose, small toxicity, small toxicity), three effects (high efficiency, quick effect, long-term effect), and five conveniences (production, transportation, taking, carrying, storage)", realizing the synchronization of traditional Chinese medicine and modern life, so that good medicine is no longer bitter.

Strong R&D capabilities are the foundation of Shineway Pharmaceutical's sustainable development. Shenwei Pharmaceutical Co., Ltd. has set up a postdoctoral research station, introduced senior professional and technical personnel including postdoctoral fellows, and actively carried out pharmaceutical research and clinical research on new Chinese medicines, improved the technical standards of existing products and developed new products in the fields of "inheritance without mud and innovation without departing from the ancestry", market-oriented, science and technology, and modernization of traditional Chinese medicine as the core. In recent years, Shenwei Pharmaceutical has successfully completed the large-scale commercial production of dozens of modern Chinese medicine products such as Shenmai Injection, Qingkailing Injection, Wufu Xinnaoqing Soft Capsules, etc., and has successively developed more than 10 national new drugs, forming a new product pattern of "production generation, reserve generation, development generation and research generation".

The national new drug lipid-lowering Tongluo soft capsule has been included in the national high-tech research and development plan (863) "Innovative Drugs and Traditional Chinese Medicine Modernization" major scientific and technological special project, and by the National Development and Reform Commission included in the "lipid-lowering Tongluo soft capsule high-tech industrialization demonstration project" project, is a national key new product jointly recognized by the Ministry of Science and Technology and other national ministries and commissions.

Summary. Shenwei Pharmaceutical Co., Ltd. focuses on the development of new dosage forms and new products of modern Chinese medicine, and has formed a strong advantageous product portfolio featuring three major dosage forms of modern Chinese medicine injection, Chinese medicine soft capsules and Chinese medicine granules, with an annual output of 1.2 billion modern Chinese medicine injections and 3.5 billion soft capsules, both of which rank first in China.

How is the work in the workshop of Shenwei Pharmaceutical

Hello, I am inquiring for you, please wait patiently for about five minutes, now the number of people waiting is relatively large, I will reply to you <> immediately

Hello, glad to answer for you. The average monthly salary of general workers in Shenwei Pharmaceutical workshop is: 3500-5000 yuan per month, three insurances and one housing fund, including food and housing, and the average salary of workshop operators is 5623 yuan per month (as of 2018), of which 33% of the salary income is located in the range of 3000-4000 yuan per month, and 33% of the wage income is located in the range of 4000-5000 yuan per month.

Shenwei Pharmaceutical Co., Ltd. focuses on the development of new dosage forms and new products of modern Chinese medicine, and has formed a strong advantageous product portfolio featuring three major dosage forms of modern Chinese medicine injection, Chinese medicine soft capsules and Chinese medicine granules, with an annual output of 1.2 billion modern Chinese medicine injections and 3.5 billion soft capsules, both of which rank first in China.

Dear I hope the above will help you If you are satisfied with me, please give a thumbs up <>

Extended information: Shenwei Pharmaceutical Group (full name Shenwei Pharmaceutical Group****) is a large-scale comprehensive enterprise group with modern Chinese medicine as its main business, founded in 1970 and headquartered in Shijiazhuang City, Hebei Province. In 1970, the predecessor of the company, Nanwang Middle School Wuqi Chemical Plant, was established.

On December 2, 2004, the company was successfully listed on the main board of Hong Kong.

Summary. I am happy to answer for you, my answer is as follows: Shenwei Pharmaceutical has a good salary, the salary of the R&D department is about 6000, and the company provides dormitories.

The average salary of Shenwei Pharmaceutical is 4,485 yuan per month, of which 36% of the salary income is located in the range of 5,000-6,000 yuan per month, and 27% of the salary income is located in the range of 3,000-4,000 yuan per month. According to the analysis of statistics, the average year-end bonus of Shenwei Pharmaceutical is 14,100 yuan. Shenwei Pharmaceutical employees shared:

It will be raised once in two or three years, or the salary will be increased if the position is promoted The general salary adjustment is about 5%, and the promotion is 15-20% The company is divided into monthly basic salary + performance (performance pay is paid every three months) and year-end bonus.

How is Shenwei Pharmaceutical's treatment?

What is the salary of the R&D department of Shineway Pharmaceutical?

Does the company provide dormitories?

I am happy to answer for you, my answer is as follows: Shenwei Pharmaceutical has a good salary, the salary of the R&D department is about 6000, and the company provides dormitories. The average salary of Shenwei Pharmaceutical is 4,485 yuan per month, of which 36% of the salary income is located in the range of 5,000-6,000 yuan per month, and 27% of the salary income is located in the range of 3,000-4,000 yuan per month.

According to the analysis of statistics, the average year-end bonus of Shenwei Pharmaceutical is 14,100 yuan. Shenwei Pharmaceutical employees shared: Once in two or three years, or if the position is promoted, the salary will be increased About 5% if the salary is generally raised, and 15-20% if promoted. The company is divided into monthly basic salary + performance (performance pay is paid every three months) and year-end bonus.

How many hours of shifts, do you work in shifts?

Yes, dear, 8-hour system.

Overtime. Are there any holidays?

What about the benefits?

Dear, unless you are very busy, you won't be able to work overtime, and you don't have to worry about overtime pay. There are also holidays and benefits on holidays.

Summary. Dear, hello, the acquisition of Shenwei Pharmaceutical is fake, and there is no official guarantee news. Founded in 1970 and headquartered in Shijiazhuang City, Hebei Province, Shenwei Pharmaceutical Group (full name Shenwei Pharmaceutical Group) is a large-scale comprehensive enterprise group with modern Chinese medicine as its main business.

In 1970, the predecessor of the company, Nanwang Middle School Wuqi Chemical Plant, was established. On December 2, 2004, the company was successfully listed on the main board of Hong Kong. The main business covers the upstream, midstream and downstream industrial chains such as Chinese herbal medicine planting, Chinese patent medicine scientific research, extraction, production, marketing, etc., and is a professional manufacturer of modern Chinese medicine injections, soft capsules and granules.

Shenwei Pharmaceutical Co., Ltd. focuses on the development of new dosage forms and new products of modern Chinese medicine, and has formed a strong advantageous product portfolio featuring three major dosage forms of modern Chinese medicine injection, Chinese medicine soft capsules and Chinese medicine granules, with an annual output of 1.2 billion modern Chinese medicine injections and 3.5 billion soft capsules, both of which rank first in China. The fist products Qingkailing Injection and Shenmai Injection occupy more than 60% of the domestic market share, Wufu Xinnaoqing Soft Capsule brings health to millions of middle-aged and elderly people every year, and Huoxiang Zhengqi Soft Capsule and other products are well-known throughout the country. 13 varieties such as Qingkailing soft capsules have been listed as national protected varieties of traditional Chinese medicine, and Wufu Xinnao Qing soft capsules and Shenwei Huoxiang Zhengqi soft capsules have been recognized as green standard products by the China Chamber of Commerce for Import and Export of Medicines and Health Products.

Is Shenwei Pharmaceutical Group intended to be acquired by a central enterprise?

Dear, hello, the acquisition of Shenwei Pharmaceutical is fake, and there is no official guarantee news. Shenwei Pharmaceutical Group (full name Shenliang Suiwei Pharmaceutical Group) is a large-scale comprehensive enterprise group with modern Chinese medicine as its main business, founded in 1970 and headquartered in Shijiazhuang City, Hebei Province. In 1970, the predecessor of the company, Nanwang Middle School Wuqi Chemical Plant, was established.

On December 2, 2004, the company was successfully listed on the main board of Hong Kong. The main business covers the upstream, midstream and downstream industrial chains such as Chinese herbal medicine planting, Chinese patent medicine scientific research, extraction, production, marketing, etc., and is a professional manufacturer of modern Chinese medicine injections, soft capsules and granules. Shenwei Pharmaceutical Co., Ltd. mainly focuses on the development of new dosage forms and new products of modern Chinese medicine, and has formed a strong advantageous product portfolio featuring three major dosage forms of modern Chinese medicine injection, Chinese medicine soft capsules and Chinese medicine granules, with an annual output of 1.2 billion modern Chinese medicine injections and 3.5 billion soft capsules, both of which rank first in China.

The fist products Qingkailing Injection and Shenmai Injection occupy more than 60% of the domestic market share, Wufu Xinnao Qingsoft Duanla Capsule brings health to millions of middle-aged and elderly people every year, and Huoxiang Zhengqi Soft Capsule and other products are well-known throughout the country. 13 varieties such as Qingkailing soft capsules have been listed as national protected varieties of traditional Chinese medicine, and Wufu Xinnao Qing soft capsules and Shenwei Huoxiang Zhengqi soft capsules have been recognized as green standard products by the China Chamber of Commerce for Import and Export of Medicines and Health Products.

At present, there is no central enterprise to acquire Shenwei Pharmaceutical Group.

Hello, I am Xiao Qingtian, the life and livelihood mentor, and I am happy to answer for you. Shenwei Pharmaceutical's company concept is still very good. With the tenet of "pursuing excellent quality and creating high-quality Chinese medicine", we will run through the whole process of enterprise management with strict detail, ensure that the system and standards are in place with meticulous spirit and high degree of execution, and do a good job in every detail.

In Shenwei, strictness is not only a quality management method, but also a quality culture. The culture of strictness is first reflected in daily behavior. Shenwei not only standardizes the behavior of employees through various strict management to make them develop good living habits, but also improves the quality of employees through continuous detailed processes and refinement systems, and implements the idea that details determine success or failure into every work.

From the source to the end, Shenwei has realized the informatization, automation and standardization of traditional Chinese medicine production. The quality assurance of the six products is permeated with Shenwei's reverence for life, the protection of health, and the persistent pursuit of traditional Chinese medicine, which is also Shenwei's greatest commitment to integrity, quality and responsibility. Hope mine can help you!

Seek <>

Hello, I am happy to serve you and give you the following answer: Shenwei Pharmaceutical is not **, but its shareholding structure has changed. According to the Company Law of the People's Republic of China, the solutions and practical steps for the change of shareholding structure are as follows:

1.The board of directors of the company shall put forward a proposal for the change of the shareholding structure and submit the proposal report to the general meeting of shareholders for deliberation. 2.

The general meeting of shareholders shall deliberate and make a decision on the proposal for the change of shareholding structure. 3.The board of directors of the company shall, in accordance with the decision of the general meeting of shareholders, go through the procedures for changing the equity structure in accordance with the procedures prescribed by law.

4.The board of directors of the company shall submit the report on the results of the change of the shareholding structure to the shareholders' general meeting for deliberation. 5.

The general meeting of shareholders shall deliberate on the report on the results of the change in shareholding structure and make a decision. Personal tip: A change in shareholding structure is an important matter that must be handled in accordance with the procedures prescribed by law to ensure the normal operation of the company.

Shenwei Pharmaceutical is not a state-owned enterprise, but a collective joint-stock company.

It is a large-scale enterprise specializing in the research and development, production and sales of modern Chinese medicine, one of the top 100 pharmaceutical companies in China, one of the top 10 in the Chinese medicine industry, and one of the largest pharmaceutical listed companies in Hong Kong main board by market capitalization.

The company has successively won hundreds of honorable titles, such as China's Top 10 Most Appreciated Pharmaceutical Enterprises, China's Outstanding Enterprise in Harmonious Labor Relations, China's Enterprise Culture Excellence Award, China's Top 100 Employers in Top 100 Industries, China's Top 100 Growing Enterprises, the National "May Day" Labor Award, and the National Advanced Collective of Traditional Chinese Medicine System.

Development goals: In the next five years, Shenwei Pharmaceutical will continue to focus on the R&D, production and sales of modern Chinese medicine, focusing on cultivating the core competitiveness of demand-oriented R&D, lean production with cost and quality as the requirements, marketing with traditional channels as the ultimate goal of controlling the terminal, and Shenwei culture with strict and realistic as the core, so as to build a first-class modern Chinese medicine brand, lead modern Chinese medicine and promote the health industry.

Core Values:

Respecting life is our eternal pursuit: to treat patients' lives with high-efficiency drugs, to improve the quality of life with high-quality products, and to cherish the life of the enterprise with a responsible attitude. All actions must be measured against this and work tirelessly to achieve this goal to the greatest extent possible. <>